Literature DB >> 26350028

Global quantitative proteomic analysis of human glioma cells profiled host protein expression in response to enterovirus type 71 infection.

Lei-Ke Zhang1, Tao Lin2, Sheng-Lin Zhu1, Ling-Zhi Xianyu2, Song-Ya Lu2.   

Abstract

Enterovirus 71 (EV71) is one of the leading causes of hand, foot and mouth disease with neurological complications in some cases. To study the pathogenesis of EV71 infection, large-scale analyses of EV71 infected cells have been performed. However, most of these studies employed rhabdomyosarcoma (RD) cells or used transcriptomic strategy. Here, we performed SILAC-based quantitative proteomic analysis of EV71-infected U251 cells, a human glioma cell line. A total of 3125 host proteins were quantified, in which 451 were differentially regulated as a result of EV71 infection at 8 or 20 hpi or both. Gene Ontology analysis indicates the regulated proteins were enriched in "metabolic process", "biological regulation" and "cellular process", implying that these biological processes were affected by EV71 infection. Furthermore, functional study indicated that TRAF2 and TRAF6 among the up-regulated proteins could inhibit the replication of EV71 at the early phase post infection, and the anti-EV71 function of both proteins was independent of interferon β. Our study not only provided an overview of cellular response to EV71 infection in a human glioma cell line, but also found that TRAF2 and TRAF6 might be potential targets to inhibit the replication of EV71. All MS data have been deposited in the ProteomeXchange with identifier PXD002454 (http://proteomecentral.proteomexchange.org/dataset/PXD002454).
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cell biology; EV71; Quantitative proteomics; SILAC; TRAF2; TRAF6

Mesh:

Substances:

Year:  2015        PMID: 26350028     DOI: 10.1002/pmic.201500134

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  Prohibitin plays a critical role in Enterovirus 71 neuropathogenesis.

Authors:  Issac Horng Khit Too; Isabelle Bonne; Eng Lee Tan; Justin Jang Hann Chu; Sylvie Alonso
Journal:  PLoS Pathog       Date:  2018-01-11       Impact factor: 6.823

2.  Quantitative Proteomic Analysis Reveals Unfolded-Protein Response Involved in Severe Fever with Thrombocytopenia Syndrome Virus Infection.

Authors:  Lei-Ke Zhang; Bo Wang; Qilin Xin; Weijuan Shang; Shu Shen; Gengfu Xiao; Fei Deng; Hualin Wang; Zhihong Hu; Manli Wang
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

3.  Enterovirus 71 Activates GADD34 via Precursor 3CD to Promote IRES-Mediated Viral Translation.

Authors:  Hui Li; Wenqian Li; Shuangling Zhang; Manman Qiu; Zhuoran Li; Yongquan Lin; Juan Tan; Wentao Qiao
Journal:  Microbiol Spectr       Date:  2022-01-05

4.  Oblongifolin M, an active compound isolated from a Chinese medical herb Garcinia oblongifolia, potently inhibits enterovirus 71 reproduction through downregulation of ERp57.

Authors:  Mengjie Wang; Qi Dong; Hua Wang; Yaqing He; Ying Chen; Hong Zhang; Rong Wu; Xinchun Chen; Boping Zhou; Jason He; Hsiang-Fu Kung; Canhua Huang; Yuquan Wei; Jian-dong Huang; Hongxi Xu; Ming-Liang He
Journal:  Oncotarget       Date:  2016-02-23

5.  A Comparative Quantitative Proteomic Analysis of HCMV-Infected Cells Highlights pUL138 as a Multifunctional Protein.

Authors:  Yang Li; Weijuan Shang; Gengfu Xiao; Lei-Ke Zhang; Congyi Zheng
Journal:  Molecules       Date:  2020-05-28       Impact factor: 4.411

Review 6.  Enteroviral proteases: structure, host interactions and pathogenicity.

Authors:  Olli H Laitinen; Emma Svedin; Sebastian Kapell; Anssi Nurminen; Vesa P Hytönen; Malin Flodström-Tullberg
Journal:  Rev Med Virol       Date:  2016-05-04       Impact factor: 6.989

7.  Global Gene Expression Analysis of the Brainstem in EV71- and CVA16-Infected Gerbils.

Authors:  Yi-Sheng Sun; Zhang-Nv Yang; Fang Xu; Chen Chen; Hang-Jing Lu; Jian-Min Jiang; Yan-Jun Zhang; Han-Ping Zhu; Ping-Ping Yao
Journal:  Viruses       Date:  2019-12-30       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.